Manufacturing

Review of SUT Adoption in Biopharma Manufacturing

The evolution of therapeutic modalities drives the adoption of single-use technologies.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Automating the Future of Fill/Finish

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

Sustainable Alternative: PFAS-Free-TPE for Pharmaceutical Stoppers

August 11, 2025

Thermoplastic elastomers (TPE) offer a PFAS-free solution for stoppers in parenteral packaging, ensuring a safer and more sustainable product.

FDA Moves to Strengthen Drug Supply Chain with PreCheck Program

August 07, 2025

The agency’s new program is designed to increase regulatory predictability and streamline review of domestic manufacturing facilities.

Bora Pharmaceuticals to Expand Midwest Manufacturing Site

August 07, 2025

The investment will expand the company’s manufacturing and packaging capabilities at its Maple Grove, Minn. site, which Bora acquired in 2024 with its acquisition of Upsher-Smith Laboratories.

Discussing Pragmatic Solutions to Ground Industry Innovations with Avantor

August 06, 2025

Jerry Keybl, senior vice-president, Biopharma Products and Strategy, Avantor, discusses innovations in biomanufacturing and recalls his impressions of INTERPHEX 2025 held this past April.

The Future of Pharma: Connected, Continuous, and Compliant

August 06, 2025

Pharma manufacturing is headed toward smarter tools, deeper partnerships, and a renewed focus on compliance and quality at every stage of the product lifecycle.

ESTEVE CDMO Acquires Regis Technologies

August 06, 2025

The acquisition expands the CDMO’s small-molecule API development and manufacturing services in the US.

How FDA’s ISTAND Initiative Supports Innovative Tools in Drug Discovery and Development

August 04, 2025

The program has been transitioned to a permanent pathway that is designed to support innovative tools like artificial intelligence, wearables, and biomarkers in drug development and trials.

Trump Sends Letters to 17 Leading Pharma Companies Outlining Most-Favored-Nation Drug Pricing Protocol

August 01, 2025

If action is not taken within 60 days, the White House said it would “deploy every tool in our arsenal” to improve drug pricing practices for American patients.

Survey: Impacts of Tariffs and Trade Policy on the Bio/pharmaceutical Industry

August 01, 2025

Help us get a better picture of how new tariffs and trade policy have impacted you and your organization.

FDA Changes Opioid Pain Medication Labeling Requirements

August 01, 2025

The changes, required for safety labeling of all opioid drugs, will emphasize the risks with long-term use to combat misuse and addiction.